Mirador Therapeutics: Series BDevelops next-generation therapies for immune-mediated inflammatory and fibrotic diseasesOct 4, 2026RoundOSMirador TherapeuticsCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesNorth AmericaSeries B